Literature DB >> 25932679

Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor.

Klaus-Dieter Preuss, Michael Pfreundschuh, Martin Weigert, Natalie Fadle, Evi Regitz, Boris Kubuschok.   

Abstract

Entities:  

Year:  2015        PMID： 25932679      PMCID： PMC4463221          DOI： 10.1172/JCI82091

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  HLA polymorphism and risk of multiple myeloma.

Authors:  Meral Beksac; Loren Gragert; Stephanie Fingerson; Martin Maiers; Mei-Jie Zhang; Mark Albrecht; Xiaobo Zhong; Wendy Cozen; Angela Dispenzieri; Sagar Lonial; Parameswaran Hari
Journal:  Leukemia       Date:  2016-07-27       Impact factor: 11.528

2.  Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.

Authors:  Xisheng Li; Jun Yan; Rong Fan; Bin Luo; Qingmei Zhang; Yongda Lin; Sufang Zhou; Guorong Luo; Xiaoxun Xie; Shaowen Xiao
Journal:  Oncol Lett       Date:  2017-03-03       Impact factor: 2.967

3.  The riddle of lymphoma BCR-antigenes.

Authors:  Lorenz Thurner; Sylvia Hartmann; Klaus-Dieter Preuss; Moritz Bewarder
Journal:  Oncotarget       Date:  2018-11-09

4.  A methylated lysine is a switch point for conformational communication in the chaperone Hsp90.

Authors:  Alexandra Rehn; Jannis Lawatscheck; Marie-Lena Jokisch; Sophie L Mader; Qi Luo; Franziska Tippel; Birgit Blank; Klaus Richter; Kathrin Lang; Ville R I Kaila; Johannes Buchner
Journal:  Nat Commun       Date:  2020-03-05       Impact factor: 14.919
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.